Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic

This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.

Detalles Bibliográficos
Autores principales: Billioti de Gage, Sophie, Drouin, Jérôme, Desplas, David, Cuenot, François, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747036/
https://www.ncbi.nlm.nih.gov/pubmed/33331873
http://dx.doi.org/10.1001/jamaophthalmol.2020.5594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747036/
https://www.ncbi.nlm.nih.gov/pubmed/33331873
http://dx.doi.org/10.1001/jamaophthalmol.2020.5594

Ejemplares similares